GLP-1 medications slow stomach emptying, so large or heavy meals can sit longer, says Rashika Bansal, MD, an assistant professor of endocrinology, metabolism, and nutrition at the Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey
TROA would expand Medicare coverage of intensive behavioral therapy for obesity and allow Part D coverage of obesity drugs
In a press announcement published March 3, 2026 (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making claims that implied sameness with FDA-approved products - specifically calling out companies that advertised drug products in ways that obscured the compounded nature of the product
Bio Glutethione de Denova
NICE guidance on obesity management recommends evidence-based pharmacological interventions alongside structured lifestyle support